Amniotic Membrane Global Market Report 2024

The amniotic membrane market has grown strongly in recent years. It will grow from $1.61 billion in 2023 to $1.74 billion in 2024 at a compound annual growth rate (CAGR) of 8.2%. The growth observed in the historical period can be attributed to various factors, including increasing patient demand for effective medical treatments, advancements in medical technologies, ongoing research in wound healing, innovations in surgical techniques, and the evolution of burn treatment methods. These factors collectively contributed to the development and progress in the utilization of amniotic membrane products for various medical applications during that period.

The amniotic membrane market is expected to see strong growth in the next few years. It will grow to $2.53 billion in 2028 at a compound annual growth rate (CAGR) of 9.8%. The anticipated growth in the forecast period can be attributed to the expanding applications of amniotic membrane products, the growth of regenerative medicine, an increase in the prevalence of chronic diseases, the demographic shift toward an aging population, and ongoing clinical trials and research. Key trends expected in the forecast period include a focus on patient-centric healthcare, recognition of anti-inflammatory effects, emphasis on clinical validation and research, innovations in biological dressing, and the development of customized and personalized treatments in the field of amniotic membrane applications.

The anticipated increase in the number of transplants is poised to drive the growth of the amniotic membrane market. Transplantation involves the surgical transfer of tissue or organs from a donor to a recipient, and amniotic membrane is utilized in such procedures. In 2021, the Australian Department of Health and Aged Care reported a significant rise in tissue transplant recipients, with 10.81 thousand reported cases from 3 thousand tissue donors. This included 2.7 thousand living tissue donors, representing a doubling compared to the figures in 2020. The escalating number of transplants is a key factor fueling the growth of the amniotic membrane market.

The increasing prevalence of chronic diseases is also expected to contribute significantly to the growth of the amniotic membrane market. Chronic diseases, lasting for three months or more and progressively worsening, are on the rise globally. The unique properties of amniotic membrane, such as its anti-inflammatory and regenerative capabilities, make it a valuable resource in managing chronic conditions, mitigating complications, and addressing tissue damage. The versatility of amniotic membrane across various medical specialties caters to the demand for effective therapeutic solutions associated with chronic diseases. According to the National Center for Biotechnology Information (NCBI) in January 2023, the projected number of people with chronic diseases worldwide is expected to reach 142.66 million by the year 2050, up from 71.522 million in 2020. This increasing prevalence of chronic diseases stands as a driving force behind the growth of the amniotic membrane market.

Major players in the amniotic membrane market are strategically focusing on the development of new surgical wound solutions to gain a competitive advantage. Surgical wounds are intentional incisions or injuries made during surgical procedures. An example of this trend is observed in the actions of MiMedx Group Inc., a biomedical company based in Georgia. In September 2022, the company launched AMNIOEFFECT, a tri-layer PURION processed human tissue allograft specifically designed for surgical procedures. This product supports the healing cascade by facilitating the development of granulation tissue. Comprising the amnion, intermediate, and chorion membrane layers of the placenta, AMNIOEFFECT enhances MiMedx's Surgical Recovery product portfolio. It provides a biocompatible human extracellular matrix (ECM) and retains over 300 regulatory proteins. The tissue offers superior handling characteristics, enabling surgeons to secure tissue in place with sutures for addressing surgical wounds.

Major companies in the amniotic membrane market are also investing in the development of new allografts to maintain a competitive edge. Allografts involve the transplantation of tissues or organs from one individual (the donor) to another individual (the recipient) within the same species. Amnio Technology LLC, a US-based biotechnology company, exemplifies this trend. In February 2022, the company launched two innovative dual-layer amniotic tissue allografts - PalinGen Dual-Layer Membrane and Dual Layer PalinGen X-Membrane. These products, designed for patients with non-healing acute and chronic wounds, complex surgical wounds, and burns, offer enhanced durability and slower resorption. Their dual-layered structure allows for unidirectional application with two outward-facing epithelial sides, contributing to improved wound management. Developed through the proprietary Advantek process, these allografts preserve the natural tissue's extracellular matrix components and regulatory proteins.

In April 2021, Katena Products Inc., a US-based provider of ophthalmic instruments and biologics, made an undisclosed acquisition of ASICO, LLC. ASICO, LLC, a US-based company operating in amniotic membranes, enhances Katena's ophthalmic surgical portfolio, expanding its global reach.

Major companies operating in the amniotic membrane market report are Alliqua BioMedical Inc., Amnio Technology LLC, Applied Biologics LLC, Human Regenerative Technologies LLC, Rivela DermaScience, Katena Products Inc., MiMedx Group Inc., Skye Biologics Inc., Amniox Medical Inc., Integra LifeSciences Co., Organogenesis Holdings Inc., Bio-Tissue Inc., Stryker Corporation, Osiris Therapeutics Inc., Sandlot Medical LLC, FzioMed Inc., Tissue-Tech Inc., DermaSciences Inc., Laboratoire CCD, VIVEX Biologics Inc., Merakris Therapeutics Inc., Thea Pharma Inc., Centauri Therapeutics Inc., Celularity Inc., IOP Ophthalmics, John Bean Technologies Corporation, Air T Inc., Mallaghan Engineering Ltd., Bharat Earth Movers Limited, Cavotec SA, Textron Inc., Vestergaard Company.

North America was the largest region in the amniotic membrane market share in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the amniotic membrane market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the amniotic membrane market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary products derived from the amniotic membrane include cryopreserved amniotic membrane and lyophilization amniotic membrane. Lyophilization amniotic membrane involves the preservation process of freezing something rapidly and then subjecting it to a vacuum to remove ice. These products find diverse applications in surgical wounds, ophthalmology, and other medical fields. They are utilized in hospitals, ambulatory surgical centers (ASCs), specialty clinics, as well as research and academic institutes.

The amniotic membrane market research report provides amniotic membrane market statistics, including amniotic membrane industry global market size, regional shares, competitors with an amniotic membrane market share, detailed amniotic membrane market segments, market trends and opportunities, and any further data you may need to thrive in the amniotic membrane industry. This amniotic membrane market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The amniotic membrane market consists of sales of epithelium, basement membrane, and stroma. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.